Veru Inc. (VERU)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
VERU Insider Trading Activity
VERU Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $106,047 | 5 | 45 |
Sells | $334,454 | 6 | 55 |
Related Transactions
| Rankowitz Michael L | director | 2 | $84,351 | 0 | $0 | $84,351 |
| FISCH HARRY | Chief Corporate Officer | 2 | $14,999 | 0 | $0 | $14,999 |
| BARNETTE K GARY | Chief Scientific Officer | 1 | $6,697 | 0 | $0 | $6,697 |
| STEINER MITCHELL SHUSTER | President and CEO | 0 | $0 | 6 | $334,454 | $-334,454 |
About Veru Inc.
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N. agencies, nonprofit organizations, and commercial partners. The company's development drug candidates include Enobosarm, an oral selective androgen receptor agonist that is in phase III clinical trial …
Insider Activity of Veru Inc.
Over the last 12 months, insiders at Veru Inc. have bought $106,047 and sold $334,454 worth of Veru Inc. stock.
On average, over the past 5 years, insiders at Veru Inc. have bought $71,645 and sold $1.77M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Rankowitz Michael L (director) — $84,351. FISCH HARRY (Chief Corporate Officer) — $14,999. BARNETTE K GARY (Chief Scientific Officer) — $6,697.
The last purchase of 54,721 shares for transaction amount of $31,919 was made by Rankowitz Michael L (director) on 2025‑02‑19.
List of Insider Buy and Sell Transactions, Veru Inc.
| 2025-02-19 | Rankowitz Michael L | director | 54,721 0.0396% | $0.58 | $31,919 | -7.74% | ||
| 2025-02-18 | Rankowitz Michael L | director | 95,279 0.0662% | $0.55 | $52,432 | -4.01% | ||
| 2024-05-24 | Sale | STEINER MITCHELL SHUSTER | President and CEO | 63,379 0.042% | $1.23 | $78,102 | -36.24% | |
| 2024-05-24 | FISCH HARRY | Chief Corporate Officer | 4,000 0.0027% | $1.25 | $5,000 | -36.24% | ||
| 2024-05-24 | BARNETTE K GARY | Chief Scientific Officer | 5,000 0.0036% | $1.34 | $6,697 | -36.24% | ||
| 2024-05-23 | Sale | STEINER MITCHELL SHUSTER | President and CEO | 300 0.0002% | $1.35 | $405 | -38.16% | |
| 2024-05-22 | Sale | STEINER MITCHELL SHUSTER | President and CEO | 6,504 0.0045% | $1.39 | $9,018 | -42.37% | |
| 2024-05-17 | Sale | STEINER MITCHELL SHUSTER | President and CEO | 28,066 0.0177% | $1.32 | $36,988 | -39.80% | |
| 2024-05-16 | Sale | STEINER MITCHELL SHUSTER | President and CEO | 59,788 0.0403% | $1.41 | $84,128 | -41.84% | |
| 2024-05-15 | Sale | STEINER MITCHELL SHUSTER | President and CEO | 84,021 0.0585% | $1.50 | $125,813 | -45.65% | |
| 2024-05-15 | FISCH HARRY | Chief Corporate Officer | 6,711 0.0046% | $1.49 | $9,999 | -45.65% | ||
| 2022-08-15 | Sale | Eisenberger Mario | 100,000 0.1275% | $20.04 | $2M | -77.36% | ||
| 2021-08-17 | Lu Lucy | director | 4,800 0.006% | $6.78 | $32,542 | +23.97% | ||
| 2021-06-16 | Sale | FISCH HARRY | 100,000 0.1237% | $8.35 | $835,300 | -8.26% | ||
| 2021-03-10 | Hyun Grace | director | 3,500 0.0048% | $14.09 | $49,315 | -40.69% | ||
| 2021-02-12 | Sale | STEINER MITCHELL SHUSTER | President and CEO | 20,000 0.0267% | $20.88 | $417,688 | -59.84% | |
| 2020-12-16 | Sale | STEINER MITCHELL SHUSTER | President and CEO | 250,000 0.3447% | $9.69 | $2.42M | -12.86% | |
| 2020-12-16 | Sale | BARNETTE K GARY | Chief Scientific Officer | 100,000 0.1515% | $10.65 | $1.06M | -12.86% | |
| 2020-08-26 | FISCH HARRY | 5,000 0.0075% | $2.76 | $13,800 | +195.80% | |||
| 2020-08-24 | Greco Michele | CAO and CFO | 5,000 0.0075% | $2.65 | $13,233 | +205.47% |
Insider Historical Profitability
| STEINER MITCHELL SHUSTER | President and CEO | 6942709 4.7428% | $3.36M | 12 | 39 | +4.18% |
| FISCH HARRY | Chief Corporate Officer | 774736 0.5292% | $375,282.12 | 34 | 1 | +29.19% |
| Rankowitz Michael L | director | 250000 0.1708% | $121,100.00 | 2 | 0 | |
| BARNETTE K GARY | Chief Scientific Officer | 5000 0.0034% | $2,422.00 | 3 | 1 | +34.34% |
| DEARHOLT STEPHEN M | director | 1978899 1.3519% | $958,578.68 | 6 | 22 | <0.0001% |
Historical Insider Profitability vs. Competitors
Veru Inc. (VERU) | $2,600,095 | 110 | 13.50% | $70.91M |
$2,942,496 | 100 | 17.32% | $66.91M | |
$4,898,715 | 46 | 40.74% | $73.28M | |
$329,102,560 | 42 | 30.96% | $73.82M | |
$542,300 | 40 | -14.44% | $67.8M |
VERU Institutional Investors: Active Positions
| Increased Positions | 65 | +60.19% | 10M | +16.95% |
| Decreased Positions | 35 | -32.41% | 13M | -21.58% |
| New Positions | 27 | New | 6M | New |
| Sold Out Positions | 12 | Sold Out | 3M | Sold Out |
| Total Postitions | 138 | +27.78% | 57M | -4.63% |
VERU Ownership Change vs Market
Institutional Investor Ownership
| Blackrock, Inc. | $4,322.00 | 5.69% | 8.31M | +75,732 | +0.92% | 2024-12-31 |
| Perceptive Advisors Llc | $3,371.00 | 4.44% | 6.48M | -800,000 | -10.98% | 2024-12-31 |
| Vanguard Group Inc | $3,234.00 | 4.26% | 6.22M | +19,058 | +0.31% | 2024-12-31 |
| Mpm Bioimpact Llc | $2,228.00 | 2.94% | 4.29M | +4M | New | 2024-12-31 |
| Millennium Management Llc | $1,958.00 | 2.58% | 3.76M | -2M | -32.23% | 2024-12-31 |
| Geode Capital Management, Llc | $1,559.00 | 2.05% | 3M | +57,611 | +1.96% | 2024-12-31 |
| Adage Capital Partners Gp, L.L.C. | $1,196.00 | 1.58% | 2.3M | -6M | -70.74% | 2024-12-31 |
| State Street Corp | $1,185.00 | 1.56% | 2.28M | +206,966 | +9.99% | 2024-12-31 |
| Altium Capital Management Llc | $1,055.00 | 1.39% | 2.03M | 0 | 0% | 2024-12-31 |
| Morgan Stanley | $761.00 | 1% | 1.46M | -2M | -51.43% | 2024-12-31 |